SHARE

News Alert: Citius Pharmaceuticals Receives FDA Approval For LYMPHIR™ (Denileukin Diftitox-Cxdl) Immunotherapy For The Treatment Of Adults With Relapsed Or Refractory Cutaneous T-Cell Lymphoma. Click to Read More.

Acology Inc (OTCMKTS:ACOL) reported that January marked the biggest sales month in firm’s history, shattering initial marks achieved in 4Q2016. The company executives have shown strong confidence that 1Q2017 would continue this trend, laying their optimism on sustained expansion in Canada and the inclusion of new, complimentary goods and product lines.

The details

Acology income jumped 33% over the same period in the last year. Unit sales of all goods, supported by company’s signature product, the MedTainer™, surged by 25% over last year. Cannabis industry, on both the recreational and medical side, continue to adopt the multi-purpose container as their businesses expand, causing company and its subsidiary unit, D&C Distributors LLC, to grow production to sustain pace with demand.

Additionally, Boveda humidity packs are planted in each Medtainer before shipping, bringing increased value to the product and generating greater demand for products countrywide. As Boveda’s marketing unit, Acology commence the year by reaching out to over 4,000 distributors globally, providing aggressive wholesale pricing which resulted in increasing demand for the goods. Since company’s partnership report Boveda products comprised 13% of total gross sales in the two weeks of January.

In unrelated news, Traders News Source, a known independent corporate access and equity research firm focused on micro-cap and small-cap public companies released a comprehensive report pertaining the company and the Cannabis market. The company offers plastic packaging that comprises and grinds herbs, pills, and similar small consumables.

While its initial market seems to have been mature with problems swallowing pills, the company has moved its focus toward the growing cannabis market. November state elections on cannabis legalization followed by an expansion and partnership into Canada expecting legalization has injected optimism into the shares.

Acology morphed into the medicinal marijuana business in 2015. Initially, it had advanced a product named the TSOS Container, known as “MedTainer”.